Label change control and Label Review Board.
A controlled, auditable change process from safety signal or regulatory commitment all the way through to country-level implementation — with the Label Review Board (LRB) as the decision body of record.
What we deliver
Change impact assessment
Regulatory, safety, medical, manufacturing and artwork impact captured per change request.
LRB facilitation
Agenda, pre-reads, minutes, decisions and follow-through — chaired or supported by Alnexia.
Deviation & discrepancy log
Local deviations from CCDS captured, justified, approved and reviewed periodically.
Version control
Controlled versioning, redline packs, e-signatures and audit trail.
Country implementation
Local affiliate handover with timelines, tracker entries and reminder cadence.
KPIs & dashboards
On-time implementation rate, overdue commitments, cycle time per region.
Artefacts you receive
- Change request package
- LRB minutes & decision log
- Updated CCDS / local label set
- Country implementation tracker
- Audit-ready change history
Sourced from regulators and industry leaders
- EMA — Variations guideline — European Medicines Agency
- FDA — Changes to an approved NDA/ANDA (CBE/PAS) — U.S. FDA
Ready to scope this work?
Talk to an Alnexia specialist about timelines, deliverables and pricing — no obligation.
Discuss your project